Alydia Health, which developed a device to treat postpartum hemorrhaging while part of the SLO Hothouse incubator, was acquired by a Merck spinoff for $240 million.
Read Full Article
REACH 2030 + Beyond. See what's next.
Alydia Health, which developed a device to treat postpartum hemorrhaging while part of the SLO Hothouse incubator, was acquired by a Merck spinoff for $240 million.
Read Full Article